@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_head { this: np:hasAssertion dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_assertion; np:hasProvenance dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_provenance; np:hasPublicationInfo dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_publicationInfo; a np:Nanopublication . dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_assertion a np:Assertion . dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_provenance a np:Provenance . dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_publicationInfo a np:PublicationInfo . } dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_assertion { miriam-gene:5340 a ncit:C16612 . lld:C0027627 a ncit:C7057 . dgn-gda:DGNb0edcb918cfc1a8ca80306c4e2f56e8c sio:SIO_000628 miriam-gene:5340, lld:C0027627; a sio:SIO_001121 . } dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_provenance { dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_assertion dcterms:description "[The possible mechanisms of action responsible for the antiinvasive effect were further investigated, and the data showed that compared with untreated cells the retinoic acid-treated cells: (a) secreted lower levels of collagenolytic enzymes, as demonstrated by a decreased ability of the cells to degrade [3H]proline-labeled type IV collagen substrate and by a reduction in the activity of a secreted Mr 64,000 collagenolytic enzyme detected in type IV collagen-containing polyacrylamide gels; (b) expressed lower levels of the human type IV collagenase mRNA (except in the A375P cells), as detected by Northern blot analysis; (c) exhibited decreased levels of tissue plasminogen activator activity, as demonstrated by a chromogenic assay; (d) were 10-40% less adhesive to a reconstituted basement membrane matrix, as determined by a 60-min Na2(51)CrO4-labeled cell attachment assay; (e) exhibited an increase in the high affinity metastasis-associated cell surface laminin receptor, as determined by flow cytometry after binding of fluorescently labeled laminin receptor antibody; and (f) expressed decreased amounts of gp78, a cell surface receptor for motility factor, demonstrated by immunoblotting and immunofluorescence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:2162253; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP278002.RAU7k_iwT98ou_TGwCZet3oUyNyeT8cf1VJLhs_k2Z0ZE130_publicationInfo { this: dcterms:created "2014-10-02T12:34:36+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }